Title

Evaluating the Effect of Sodium Zirconium Cyclosilicate in Acute Hyperkalemia Management

Authors

Austin Brandes
Hannah Thompson, CentraCare, PharmacyFollow
Paul Huiras, CentraCare, PharmacyFollow

Files

Description

Introduction

• Sodium zirconium cyclosilicate (ZS-9) can acutely decrease serum potassium (K) levels after one dose and may have favorable side effects compared to sodium polystyrene sulfate (SPS).
• ZS-9 replaced oral SPS in the Hyperkalemia Order Set at St. Cloud Hospital in April 2019

Purpose

• To characterize the acute potassium-lowering effects of one 10-gram dose of sodium zirconium cyclosilicate in conjunction with other potassium-lowering medications

Publication Date

2019

City

St. Cloud

Keywords

Sodium zirconium cyclosilicate, Acute hyperkalemia, Acute hyperkalemia managementZS-9, Silicates-therapeutic use, Zirconium-therapeutic use

Disciplines

Chemicals and Drugs | Other Pharmacy and Pharmaceutical Sciences

Comments

Poster presented at The American Society of Health-System Pharmacists Midyear Clinical Meeting, December 8-12, 2019; Las Vegas, NV

Recommended Citation

Brandes, Austin; Thompson, Hannah; and Huiras, Paul, "Evaluating the Effect of Sodium Zirconium Cyclosilicate in Acute Hyperkalemia Management" (2019). Pharmacy Posters. 6.
https://digitalcommons.centracare.com/pharmacy_posters/6